Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > Mengel suggests adding CRDL....
View:
Post by Youhillman on Mar 02, 2021 11:34am

Mengel suggests adding CRDL....

The following is out today from the Cannabis guru Jimmy Mengel; it's after the NASDAQ announcement CRDL made this morning....


In other cannabis news, today Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) announced a plan to uplist to the NASDAQ.

Cardiol Therapeutics is a biotechnology company specializing in the research and commercial development of novel drug therapies utilizing proprietary drug-delivery systems. The company is developing CBD medications for chronic heart failure, which affects more than 26 million people globally.

Over six million adults in Canada and the United States suffer from chronic heart failure and it remains a leading cause of death and hospitalization, with associated healthcare costs exceeding $30 billion annually in the U.S. alone.

Cardiol is already up 49% this year. I would suggest adding it to your portfolio if you haven't yet.

Comment by Mapleleaf57 on Mar 02, 2021 1:48pm
you should BUY BUY BUY,,,,,  its a great price now,,,, LOL
Comment by Youhillman on Mar 02, 2021 2:57pm
Wow, with CRDL being down 5% today vs. the rest of the market being basically flat....it's the first time you've ever stated something that is factually correct and worthwhile! Today is a good day to buy and so I have added to my already extensive holdings of CRDL!  
Cardiol Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities